Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Neuralstem Inc (CUR)

Neuralstem Inc (CUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neuralstem Inc 20271 Goldenrod Lane Germantown MD 20876 USA

www.neuralstem.com P: 301-366-4841

Description:

NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.

Key Statistics

Overview:

Market Capitalization, $K 3,192
Shares Outstanding, K 2,100
Annual Sales, $ 260 K
Annual Net Income, $ -4,920 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -1,440 K
60-Month Beta 1.81
% of Insider Shareholders 5.38%
% of Institutional Shareholders 38.30%
Float, K 1,987
% Float 94.62%

Growth:

1-Year Return -86.78%
3-Year Return -97.46%
5-Year Return -99.78%
5-Year Revenue Growth 136.36%
5-Year Earnings Growth 87.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/13/19
Earnings Per Share ttm -7.65
EPS Growth vs. Prev Qtr 57.35%
EPS Growth vs. Prev Year -81.25%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/18/19

CUR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -170.51%
Return-on-Assets % -110.16%
Profit Margin % -1,892.31%
Debt/Equity 0.00
Price/Sales 14.78
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 1.96
Interest Coverage -491.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar